Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion

Nakho Chang, Hwang Gyun Jeon|Oncotarget|2016

Cited by 14